Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid
- PMID: 15896302
- DOI: 10.1016/j.bbrc.2005.04.097
Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid
Erratum in
- Biochem Biophys Res Commun. 2005 Sep 2;334(3):969
Abstract
Muscle atrophy in a number of acute wasting conditions is associated with an increased activity and expression of the ubiquitin-proteasome proteolytic pathway. Although different initiators are involved, it is possible that the intracellular signalling events leading to upregulation of this pathway are the same in all catabolic conditions. This study investigates hyperthermia in murine myotubes as a model for increased protein degradation through the ubiquitin-proteasome pathway. The effect of eicosapentaenoic acid (EPA) on this process should identify common elements, since EPA has been shown to attenuate induction of the ubiquitin-proteasome pathway in cancer cachexia. Increasing the temperature of myotubes caused a progressive increase in protein degradation. This was associated with an increased proteasome 'chymotrypsin-like' enzyme activity, as well as increased expression of both mRNA and protein for 20S proteasome subunits and the ubiquitin-conjugating enzyme (E2(14k)). This upregulation was not seen in cultures treated with EPA (50 microM), suggesting that it acts to prevent transcriptional activation of the ubiquitin-proteasome pathway in hyperthermia. These results suggest that protein catabolism in hyperthermia and cancer cachexia is mediated through a common pathway.
Similar articles
-
Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).Biochem Biophys Res Commun. 2008 Oct 17;375(2):238-40. doi: 10.1016/j.bbrc.2008.08.004. Epub 2008 Aug 12. Biochem Biophys Res Commun. 2008. PMID: 18703014
-
Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.Life Sci. 2006 May 15;78(25):2898-910. doi: 10.1016/j.lfs.2005.11.014. Epub 2005 Dec 15. Life Sci. 2006. PMID: 16343552
-
Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.Biochem Biophys Res Commun. 2001 Jul 20;285(3):598-602. doi: 10.1006/bbrc.2001.5209. Biochem Biophys Res Commun. 2001. PMID: 11453634
-
The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.J Support Oncol. 2005 May-Jun;3(3):209-17. J Support Oncol. 2005. PMID: 15915823 Review.
-
Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.J Mol Endocrinol. 2005 Apr;34(2):281-97. doi: 10.1677/jme.1.01680. J Mol Endocrinol. 2005. PMID: 15821097 Review.
Cited by
-
Eicosapentaenoic acid enhances skeletal muscle hypertrophy without altering the protein anabolic signaling pathway.Physiol Res. 2021 Mar 17;70(1):55-65. doi: 10.33549/physiolres.934534. Epub 2021 Jan 14. Physiol Res. 2021. PMID: 33453714 Free PMC article.
-
Effect of dietary n-3 PUFA supplementation on the muscle transcriptome in older adults.Physiol Rep. 2016 Jun;4(11):e12785. doi: 10.14814/phy2.12785. Physiol Rep. 2016. PMID: 27252251 Free PMC article. Clinical Trial.
-
Hyperthermia and postmortem biochemical investigations.Int J Legal Med. 2013 Jan;127(1):93-102. doi: 10.1007/s00414-012-0722-6. Epub 2012 Jun 5. Int J Legal Med. 2013. PMID: 22669324 Review.
-
Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food.Clin Nutr. 2011 Dec;30(6):759-68. doi: 10.1016/j.clnu.2011.05.008. Epub 2011 Jun 16. Clin Nutr. 2011. PMID: 21683485 Free PMC article. Clinical Trial.
-
Theophylline is able to partially revert cachexia in tumour-bearing rats.Nutr Metab (Lond). 2012 Aug 21;9(1):76. doi: 10.1186/1743-7075-9-76. Nutr Metab (Lond). 2012. PMID: 22909172 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials